PT74252B - Immunoglobulin derivatives - Google Patents

Immunoglobulin derivatives

Info

Publication number
PT74252B
PT74252B PT74252A PT7425282A PT74252B PT 74252 B PT74252 B PT 74252B PT 74252 A PT74252 A PT 74252A PT 7425282 A PT7425282 A PT 7425282A PT 74252 B PT74252 B PT 74252B
Authority
PT
Portugal
Prior art keywords
immunoglobulin
immunoglobulin derivatives
fragment
derivatives
conjugates
Prior art date
Application number
PT74252A
Other languages
English (en)
Other versions
PT74252A (en
Inventor
George Ferdinand Rowland
Robin George Simmonds
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of PT74252A publication Critical patent/PT74252A/pt
Publication of PT74252B publication Critical patent/PT74252B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT74252A 1981-01-12 1982-01-07 Immunoglobulin derivatives PT74252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (2)

Publication Number Publication Date
PT74252A PT74252A (en) 1982-02-01
PT74252B true PT74252B (en) 1983-08-24

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
PT74252A PT74252B (en) 1981-01-12 1982-01-07 Immunoglobulin derivatives

Country Status (27)

Country Link
EP (1) EP0056322B1 (pt)
JP (1) JPS57136529A (pt)
KR (1) KR860001149B1 (pt)
AT (1) ATE16603T1 (pt)
AU (1) AU549495B2 (pt)
BG (1) BG40318A3 (pt)
CA (1) CA1180660A (pt)
CS (1) CS235525B2 (pt)
DD (1) DD201447A5 (pt)
DE (1) DE3267474D1 (pt)
DK (1) DK5982A (pt)
EG (1) EG15599A (pt)
ES (1) ES508633A0 (pt)
FI (1) FI820020L (pt)
GB (1) GB2090837B (pt)
GR (1) GR75182B (pt)
HU (1) HU186025B (pt)
IE (1) IE52239B1 (pt)
IL (1) IL64722A (pt)
MX (1) MX7215E (pt)
NZ (1) NZ199421A (pt)
PH (1) PH18031A (pt)
PL (1) PL128529B1 (pt)
PT (1) PT74252B (pt)
RO (1) RO82758B (pt)
SU (1) SU1069628A3 (pt)
ZA (1) ZA82122B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
ATE53496T1 (de) * 1983-03-30 1990-06-15 Lilly Industries Ltd Immunoglobulinkonjugate.
US4596676A (en) * 1983-03-30 1986-06-24 Lilly Industries Limited Bifunctional ester derivatives of 4-desacetyl indole-dihydroindole alkaloids
ATE64396T1 (de) * 1983-04-29 1991-06-15 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
FI860456A (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
IT1107772B (it) * 1977-08-22 1985-11-25 Cancer Res Inst Royal Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Also Published As

Publication number Publication date
RO82758A (ro) 1984-01-14
GR75182B (pt) 1984-07-13
IL64722A0 (en) 1982-03-31
PL234695A1 (pt) 1982-07-19
NZ199421A (en) 1984-08-24
JPS57136529A (en) 1982-08-23
GB2090837B (en) 1984-07-18
DK5982A (da) 1982-07-13
GB2090837A (en) 1982-07-21
DE3267474D1 (en) 1986-01-02
DD201447A5 (de) 1983-07-20
PH18031A (en) 1985-03-06
ATE16603T1 (de) 1985-12-15
PT74252A (en) 1982-02-01
HU186025B (en) 1985-05-28
EG15599A (en) 1986-06-30
MX7215E (es) 1988-01-08
CA1180660A (en) 1985-01-08
SU1069628A3 (ru) 1984-01-23
EP0056322B1 (en) 1985-11-21
BG40318A3 (en) 1986-11-14
AU7927482A (en) 1982-07-22
PL128529B1 (en) 1984-02-29
ES8304149A1 (es) 1983-02-16
EP0056322A1 (en) 1982-07-21
KR860001149B1 (ko) 1986-08-18
ZA82122B (en) 1983-07-27
CS235525B2 (en) 1985-05-15
ES508633A0 (es) 1983-02-16
KR830008684A (ko) 1983-12-12
IE820023L (en) 1982-07-12
IL64722A (en) 1985-07-31
RO82758B (ro) 1984-01-30
IE52239B1 (en) 1987-08-19
FI820020L (fi) 1982-07-13
AU549495B2 (en) 1986-01-30

Similar Documents

Publication Publication Date Title
DE3267474D1 (en) Immunoglobulin conjugates
AU7366687A (en) Coupling agents for radiolabeling proteins
IL78993A (en) Antibodies and kit for use in radiotherapy and radioimmunoassay utilizing the same
GR1000712B (el) Νεα αντισωματα που αντιδρουν με τα ανθρωπινα καρκινωματα.
NO920040D0 (no) Syrelabile linkermolekyler
DE3885317D1 (de) Makromolekulare Platin-Antitumorverbindungen.
ATE85758T1 (de) Trichotecenkonjugate.
DK0462145T3 (da) Covalente konjugater mellem lipid og oligonucleotid
IL71366A (en) Immunoglobulin conjugates with vincaleukoblastine derivatives,their production and pharmaceutical compositions containing them
DE68923291D1 (de) Antikörper-konjugate mit zwei oder mehr kovalent vernetzten fc-regionen.
EP0397700A4 (en) Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
FR2432038A1 (fr) Conjugues marques d'hydrazide d'acide naphtalene-1,2-dicarboxylique chimioluminescent et leur procede de preparation
DK0570575T3 (da) Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf
GR852914B (pt)
DE3466530D1 (de) 2,2-diethoxypropionic acid derivatives
DE3879709D1 (de) Platin-arzneimittel.
GB1515392A (en) Process for the purification of protein conjugates
SE8002602L (sv) Diagnostiskt forfarande
FR2311016A1 (fr) Carbazyl derives de la rifamycine